News
Biotesys becomes an official laboratory partner of ‘Laborgeprüft’
We are delighted to announce our new partnership with “Laborgeprüft”. Together, we are committed to greater transparency and safety in...
Find out moreBiotesys at Vitafoods Europe 2026 in Barcelona
From May 5–7, 2026, our colleague Christiane Schön will be attending Vitafoods Europe in Barcelona on behalf of Biotesys. The trade fair is the central meeting point for the nutraceutical industry and offers an excellent platform to...
Find out moreCooperation with Clinic'n'Cell
Biotesys is expanding its nutraceutical research: Together with Clinic'n'Cell, we are combining clinical studies with an innovative ex-vivo approach to investigate the relationship between human metabolism and cell biology more precisely.
Find out moreBioTeSys follows SBTi and invests in global emissions reduction
BioTeSys takes responsibility for effective decarbonization: by aligning itself with the Science Based Targets initiative (SBTi) and investing in climate protection projects, the company supports the measurable reduction of emissions worldwide.
Find out moreCooperation with daacro: Together into an innovative future
BioTeSys is cooperating with the daacro research institute to combine expertise in psychotropic substances with analytical and in vivo study expertise. The aim is an intensive exchange of knowledge and resources for forward-looking projects and even more customized solutions for customers.
Find out moreBiotesys joins CERTANIA Group
Biotesys, a leading Contract Research Organisation (CRO) specializing in the development and testing of bioactive ingredients for food supplements, cosmetics and medical devices, proudly announces its integration into the CERTANIA...
Find out more